Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Short-Term Debt repayments (2019 - 2025)

China Pharma Holdings (CPHI) has disclosed Short-Term Debt repayments for 7 consecutive years, with -$617961.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-Term Debt repayments changed N/A year-over-year to -$617961.0, compared with a TTM value of $474932.0 through Sep 2025, down 79.03%, and an annual FY2024 reading of $492761.0, down 66.93% over the prior year.
  • Short-Term Debt repayments was -$617961.0 for Q3 2025 at China Pharma Holdings, down from $1.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $1.5 million in Q3 2021 and bottomed at -$617961.0 in Q3 2025.
  • Average Short-Term Debt repayments over 4 years is $514689.0, with a median of $467486.0 recorded in 2021.
  • Peak annual rise in Short-Term Debt repayments hit 1367.38% in 2022, while the deepest fall reached 101.1% in 2022.
  • Year by year, Short-Term Debt repayments stood at $85043.0 in 2021, then soared by 1367.38% to $1.2 million in 2022, then fell by 17.15% to $1.0 million in 2023, then crashed by 159.77% to -$617961.0 in 2025.
  • Business Quant data shows Short-Term Debt repayments for CPHI at -$617961.0 in Q3 2025, $1.0 million in Q2 2025, and $76820.0 in Q1 2025.